|4Dec 23, 5:00 PM ET

Ence Chuck 4

4 · RELMADA THERAPEUTICS, INC. · Filed Dec 23, 2019

Insider Transaction Report

Form 4
Period: 2019-12-19
Ence Chuck
CAO and COO
Transactions
  • Award

    Options to purchase common stock

    2019-12-19$43.47/sh+60,000$2,608,20060,000 total
    Exercise: $43.47Exp: 2029-12-19Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant.

Documents

1 file
  • 4
    ownership.xmlPrimary